pubmed ghk cu GHK-CU GHK-Cu (Copper Peptide) | Research

The molecule was developed in the 1980s by Russian gerontologist Vladimir Khavinson at the St

There are claims BPC 157 does just that

Across preclinical studies, Epitalon has shown: Telomerase activation and telomere extension: Via TRAP assays and fibroblast lifespan extension beyond the Hayflick limit Epigenetic remodeling: Reversal of chromatin aging, histone modulation, and gene promoter binding Redox homeostasis: Increased antioxidant enzymes (SOD, NQO1, catalase) and reduced ROS, lipid peroxidation, and DNA damage Circadian restoration: Upregulation of AANAT/pCREB, normalized melatonin and cortisol rhythms, and clock gene modulation in humans Cancer risk reduction: Reduced tumor multiplicity and delayed onset in HER-2/neu and colon cancer models

What presentation is supplied

You can find GHK-Cu sold in gray-market "research" formats with no physician oversight, no sourcing transparency, and no plan